Pulmonary function of a paediatric cohort of patients with postinfectious bronchiolitis obliterans. A long term follow-up

Thorax

Volumn 70, Issue 2, 2015, Pages 169-174

  Colom, Alejandro J ^a   Maffey, Alberto ^a   Bournissen, Facundo Garcia ^a   Teper, Alejandro ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; BRONCHOPLEURAL FISTULA; CHILD; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LOBECTOMY; LUNG FUNCTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PLETHYSMOGRAPHY; PNEUMOTHORAX; POSTINFECTIOUS BRONCHIOLITIS OBLITERANS; RESIDUAL VOLUME; RESPIROMETRY; SCHOOL CHILD; SCORING SYSTEM; THORAX DEFORMITY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; TREATMENT RESPONSE; WOUND INFECTION; ADENOVIRUS INFECTION; BODY HEIGHT; COMPLICATION; INFANT; MAXIMAL MID EXPIRATORY FLOW; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SPIROMETRY; TIME; VIROLOGY; VITAL CAPACITY; YOUNG ADULT;

ADENOVIRIDAE INFECTIONS; ADOLESCENT; BODY HEIGHT; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; INFANT; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; OXYGEN INHALATION THERAPY; PATIENT READMISSION; PLETHYSMOGRAPHY; RESIDUAL VOLUME; SPIROMETRY; TIME FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 84921264456     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205328     Document Type: Article

References (30)

1. Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest 1988;93:460-6.
2. Colom AJ, Teper AM, Vollmer WM, et al. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006;61:503-6.
3. Castro-Rodriguez J, Daszenies C, Garcia M, et al. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 2006;41:947-53.
4. Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000;29:341-50.
5. Yalc¸in E, Dogru D, Haliloglu M, et al. Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors. Respiration 2003;70:371-5.
6. Lang W, Howden C, Laws J, et al. Bronchopneumonia with serious sequelae in children with evidence of adenovirus type 21 infection. BMJ 1969;1:73-9.
7. Wenman W, Pagtakhan R, Reed M, et al. Adenovirus bronchiolitis in Manitoba. Epidemiologic, clinical and radiologic features. Chest 1982;81:605-9.
8. Chang A, Masel J, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol 1998;28:23-9.
9. Kim CK, Kim SW, Kim JS, et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 2001;120:1101-6.
10. Becroft DMO. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol 1971;24:72-82.
11. Simila S, Linna O, Lanning P, et al. Chronic lung damage caused by adenovirus type 7: a ten year follow up study. Chest 1981;80:127-31.
12. Wohl ME, Chernick V. State of the art: bronchiolitis. Am Rev Respir Dis 1978;118:759-81.
13. Teper AM, Kofman CD, Maffey AF, et al. Lung function in infants with chronic pulmonary disease after severe adenoviral illness. J Pediatr 1999;134:730-3.
14. Copley SJ, Padley SPG. High-resolution CT of paediatric lung disease. Eur Radiol 2001;11:2564-75.
15. Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol 2009;44:1065-9.
16. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: The global lung function 2012 equations. Eur Respir J 2012;40:1324-43.
17. Lunn DJ, Thomas A, Best N, et al. WinBUGS - a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000;10:325-37.
18. Castile RG, Staats BA, Westbrook PR. Symptomatic pectus deformities of the chest. Am Rev Respir Dis 1982;126:564-8.
19. Cazzato S, Poletti V, Bernardi F, et al. Airway inflammation and lung function decline in childhood post-infectious bronchiolitis obliterans. Pediatr Pulmonol 2008;43:381-90.
20. Narayanan M, Beardsmore CS, Owers-Bradley J, et al. Catch-up alveolarization in ex-preterm children. Evidence from 3He magnetic resonance. Am J Respir Crit Care Med 2013;187:1104-9.
21. Narayanan M, Owers-Bradley J, Beardsmore CS, et al. Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med 2012;185:186-91.
22. Wanger J, Clausen J, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
23. De Boeck K, Smith J, Van Lierde S, et al. Flat chest in survivors of bronchopulmonary dysplasia. Pediatr Pulmonol 1994;18:104-7.
24. Edwards DK III, Hilton SW. Flat chest in chronic bronchopulmonary dysplasia. AJR Am J Roentgenol 1988;150:375.
25. Fraser R, Pare P, Pare P, et al. Diagnosis of diseases of the Chest (translation: Patrone U, Meerof N). Buenos Aires 1992:2744-55.
26. Davies H. Chest deformities in congenital heart disease. Br J Dis Chest 1959;53:151-9.
27. Gerhardt S, McDyer J, Girgis R, et al. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome. Results of a pilot study. Am J Respir Crit Care Med 2003;168:121-5.
28. Mistchenko AS, Lenzi HL, Thompson FM, et al. Participation of immune complexes in adenovirus infection. Acta Paediatr 1992;81:983-8.
29. Mistchenko AS, Diez RA, Mariani AL, et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994;124:714-20.
30. Fullmer J, Fan L, Dishop M, et al. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-innodataalpha blockade. Pediatrics 2005;116:767-70.